-
1 Comment
China Pioneer Pharma Holdings Limited is currently in a long term uptrend where the price is trading 25.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
China Pioneer Pharma Holdings Limited's total revenue sank by 10.5% to $622M since the same quarter in the previous year.
Its net income has increased by 415.4% to $31M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.2% to $101M since the same quarter in the previous year.
Based on the above factors, China Pioneer Pharma Holdings Limited gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | HK |
| CurrencyCode | HKD |
| ISIN | KYG2162L1068 |
| Dividend Yield | 5.0% |
|---|---|
| Market Cap | 3B |
| PE Ratio | 15.93 |
| Target Price | 3.39 |
| Beta | 0.29 |
Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products. In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; Medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals and medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1345.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
